
Sartorius Stedim Biotech SA
PAR:DIM

Sartorius Stedim Biotech SA?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
152.9
225.5
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Sartorius Stedim Biotech SA hold over its rivals?
What risks and challenges
does Sartorius Stedim Biotech SA face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Sartorius Stedim Biotech SA.
Provide an overview of the primary business activities
of Sartorius Stedim Biotech SA.
What unique competitive advantages
does Sartorius Stedim Biotech SA hold over its rivals?
What risks and challenges
does Sartorius Stedim Biotech SA face in the near future?
Summarize the latest earnings call
of Sartorius Stedim Biotech SA.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Sartorius Stedim Biotech SA.
Provide P/S
for Sartorius Stedim Biotech SA.
Provide P/E
for Sartorius Stedim Biotech SA.
Provide P/OCF
for Sartorius Stedim Biotech SA.
Provide P/FCFE
for Sartorius Stedim Biotech SA.
Provide P/B
for Sartorius Stedim Biotech SA.
Provide EV/S
for Sartorius Stedim Biotech SA.
Provide EV/GP
for Sartorius Stedim Biotech SA.
Provide EV/EBITDA
for Sartorius Stedim Biotech SA.
Provide EV/EBIT
for Sartorius Stedim Biotech SA.
Provide EV/OCF
for Sartorius Stedim Biotech SA.
Provide EV/FCFF
for Sartorius Stedim Biotech SA.
Provide EV/IC
for Sartorius Stedim Biotech SA.
Show me price targets
for Sartorius Stedim Biotech SA made by professional analysts.
What are the Revenue projections
for Sartorius Stedim Biotech SA?
How accurate were the past Revenue estimates
for Sartorius Stedim Biotech SA?
What are the Net Income projections
for Sartorius Stedim Biotech SA?
How accurate were the past Net Income estimates
for Sartorius Stedim Biotech SA?
What are the EPS projections
for Sartorius Stedim Biotech SA?
How accurate were the past EPS estimates
for Sartorius Stedim Biotech SA?
What are the EBIT projections
for Sartorius Stedim Biotech SA?
How accurate were the past EBIT estimates
for Sartorius Stedim Biotech SA?
Compare the revenue forecasts
for Sartorius Stedim Biotech SA with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Sartorius Stedim Biotech SA and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Sartorius Stedim Biotech SA against its competitors.
Analyze the profit margins
(gross, operating, and net) of Sartorius Stedim Biotech SA compared to its peers.
Compare the P/E ratios
of Sartorius Stedim Biotech SA against its peers.
Discuss the investment returns and shareholder value creation
comparing Sartorius Stedim Biotech SA with its peers.
Analyze the financial leverage
of Sartorius Stedim Biotech SA compared to its main competitors.
Show all profitability ratios
for Sartorius Stedim Biotech SA.
Provide ROE
for Sartorius Stedim Biotech SA.
Provide ROA
for Sartorius Stedim Biotech SA.
Provide ROIC
for Sartorius Stedim Biotech SA.
Provide ROCE
for Sartorius Stedim Biotech SA.
Provide Gross Margin
for Sartorius Stedim Biotech SA.
Provide Operating Margin
for Sartorius Stedim Biotech SA.
Provide Net Margin
for Sartorius Stedim Biotech SA.
Provide FCF Margin
for Sartorius Stedim Biotech SA.
Show all solvency ratios
for Sartorius Stedim Biotech SA.
Provide D/E Ratio
for Sartorius Stedim Biotech SA.
Provide D/A Ratio
for Sartorius Stedim Biotech SA.
Provide Interest Coverage Ratio
for Sartorius Stedim Biotech SA.
Provide Altman Z-Score Ratio
for Sartorius Stedim Biotech SA.
Provide Quick Ratio
for Sartorius Stedim Biotech SA.
Provide Current Ratio
for Sartorius Stedim Biotech SA.
Provide Cash Ratio
for Sartorius Stedim Biotech SA.
What is the historical Revenue growth
over the last 5 years for Sartorius Stedim Biotech SA?
What is the historical Net Income growth
over the last 5 years for Sartorius Stedim Biotech SA?
What is the current Free Cash Flow
of Sartorius Stedim Biotech SA?
Discuss the annual earnings per share (EPS)
trend over the past five years for Sartorius Stedim Biotech SA.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
FR |
![]() |
Sartorius Stedim Biotech SA
PAR:DIM
|
16.2B EUR | 25.8 | |
US |
P
|
PerkinElmer Inc
LSE:0KHE
|
963B USD | 1 187.7 |
|
US |
![]() |
Thermo Fisher Scientific Inc
NYSE:TMO
|
173.9B USD | 20.4 |
|
US |
![]() |
Danaher Corp
NYSE:DHR
|
143.6B USD | 22.1 |
|
KR |
![]() |
Samsung Biologics Co Ltd
KRX:207940
|
73.2T KRW | 33.2 |
|
CH |
![]() |
Lonza Group AG
SIX:LONN
|
38.1B CHF | 37.9 |
|
CN |
![]() |
WuXi AppTec Co Ltd
SSE:603259
|
262.2B CNY | 22.9 |
|
US |
![]() |
Agilent Technologies Inc
NYSE:A
|
32.5B USD | 19 |
|
US |
![]() |
IQVIA Holdings Inc
NYSE:IQV
|
30.6B USD | 12.6 |
|
US |
![]() |
Mettler-Toledo International Inc
NYSE:MTD
|
26.1B USD | 22.9 |
|
IN |
![]() |
Divi's Laboratories Ltd
NSE:DIVISLAB
|
1.6T INR | 51.5 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
FR |
![]() |
Sartorius Stedim Biotech SA
PAR:DIM
|
Average EV/EBITDA:
132.4
25.8
|
20%
|
1.3 | |
US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1 187.7
|
6%
|
197.9 |
|
US |
![]() |
Thermo Fisher Scientific Inc
NYSE:TMO
|
20.4
|
5%
|
4.1 |
|
US |
![]() |
Danaher Corp
NYSE:DHR
|
22.1
|
7%
|
3.2 |
|
KR |
![]() |
Samsung Biologics Co Ltd
KRX:207940
|
33.2
|
17%
|
2 |
|
CH |
![]() |
Lonza Group AG
SIX:LONN
|
37.9
|
18%
|
2.1 |
|
CN |
![]() |
WuXi AppTec Co Ltd
SSE:603259
|
22.9
|
24%
|
1 |
|
US |
![]() |
Agilent Technologies Inc
NYSE:A
|
19
|
10%
|
1.9 |
|
US |
![]() |
IQVIA Holdings Inc
NYSE:IQV
|
12.6
|
8%
|
1.6 |
|
US |
![]() |
Mettler-Toledo International Inc
NYSE:MTD
|
22.9
|
4%
|
5.7 |
|
IN |
![]() |
Divi's Laboratories Ltd
NSE:DIVISLAB
|
51.5
|
24%
|
2.1 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.